ShockWave Medical Inc. (SWAV)
NASDAQ: SWAV
· Real-Time Price · USD
334.75
-0.08 (-0.02%)
At close: May 30, 2024, 10:00 PM
ShockWave Medical Revenue Breakdown
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|
| Coronary Revenue | 528.85M | 353.86M | 161.46M | 24.59M |
| Coronary Revenue Growth | +49.45% | +119.16% | +556.73% | n/a |
| Other Product Line Revenue | 2.67M | 3.59M | 1.62M | 1.21M |
| Other Product Line Revenue Growth | -25.60% | +121.74% | +33.91% | n/a |
| Peripheral Revenue | 194.35M | 132.28M | 74.06M | 41.99M |
| Peripheral Revenue Growth | +46.92% | +78.61% | +76.37% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|
| All Other Countries Revenue | 71.17M | 31.3M | 12.25M | 7.21M | 2.73M |
| All Other Countries Revenue Growth | +127.39% | +155.47% | +69.87% | +164.27% | n/a |
| Europe Revenue | 77.52M | 51.01M | 38.57M | 37.12M | 22.7M |
| Europe Revenue Growth | +51.96% | +32.25% | +3.91% | +63.54% | n/a |
| United States Revenue | 581.55M | 407.43M | 186.32M | n/a | n/a |
| United States Revenue Growth | +42.74% | +118.66% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 103.72M | 92.06M | 78.36M | 86.47M | 73.22M | 60.38M | 56.52M | 53.68M | 48.35M | 42.82M | 37.66M | 34.34M | 31.22M | 23.07M | 19.23M | 16.6M | 16.64M | 14.05M | 11.63M | 10.21M | 8.87M | 6.77M | 6.17M | 5.76M | 4.81M |
| Selling, General, and Administrative Revenue Growth | +12.67% | +17.49% | -9.38% | +18.10% | +21.26% | +6.83% | +5.28% | +11.02% | +12.91% | +13.71% | +9.67% | +10.00% | +35.34% | +19.96% | +15.81% | -0.19% | +18.42% | +20.79% | +13.94% | +15.04% | +31.11% | +9.68% | +7.04% | +19.73% | n/a |
| Research and Development Revenue | 44.47M | 42.32M | 39.53M | 36.83M | 26.97M | 23.72M | 20.18M | 20.76M | 17.02M | 14.72M | 13.73M | 11.81M | 10.28M | 9.04M | 7.89M | 8.1M | 11.89M | 10.07M | 8.37M | 6.93M | 7.48M | 6.12M | 5.53M | 5.53M | 5.52M |
| Research and Development Revenue Growth | +5.07% | +7.07% | +7.32% | +36.55% | +13.69% | +17.57% | -2.81% | +21.98% | +15.64% | +7.15% | +16.25% | +14.97% | +13.63% | +14.61% | -2.59% | -31.87% | +18.01% | +20.40% | +20.82% | -7.46% | +22.31% | +10.59% | +0.05% | +0.25% | n/a |
| Sales and Marketing Revenue | 74.49M | 67.18M | 56.91M | 56.74M | 54.01M | 43.44M | 42.08M | 40.52M | 35.96M | 33.19M | 28.39M | 25.71M | 23.99M | 16.44M | 13.62M | 11.21M | 10.41M | 9.6M | 8.19M | 6.96M | 5.87M | 4.92M | 4.8M | 4.37M | 3.44M |
| Sales and Marketing Revenue Growth | +10.88% | +18.05% | +0.30% | +5.05% | +24.34% | +3.22% | +3.87% | +12.66% | +8.35% | +16.90% | +10.42% | +7.17% | +45.97% | +20.68% | +21.53% | +7.64% | +8.48% | +17.15% | +17.68% | +18.57% | +19.21% | +2.58% | +9.81% | +27.17% | n/a |